Skip to main content
. 2017 Apr 24;8(29):47595–47606. doi: 10.18632/oncotarget.17394

Figure 5. Differential expression of MKI67 between risk groups.

Figure 5

(A) Expression analysis of MKI67 determined by qRT-PCR in the low risk group (n=30) and high risk group (n=54) of the Mannheim cohort. (B) Expression analysis of MKI67 determined by Illumina microarray analysis in the low risk group (n=10) and high risk group (n=51) of the Chungbuk cohort.